Centers for Disease Control and Prevention researchers report national estimates of 43.6 million COVID-19-associated illnesses and 101,300 deaths in the US during October 2022 to September 2023, plus ...
A major new study examining the 2023-2024 COVID-19 vaccines shows moderate protection that works best in the first few months but weakens considerably over time. The research, published in JAMA ...
Infant protection against respiratory syncytial virus (RSV) by maternal RSV vaccination or receipt of RSV monoclonal antibody ...
COVID-19 is no longer a top cause of death for Americans, dropping from fourth place in 2022 to 10th place last year. The disease was listed on 49,928 death certificates in 2023 — down from 186,552 in ...
As the summer surge of COVID-19 crests, many people are weighing whether they need to get booster shots now to protect against the disease (SN: 7/19/24). The U.S. Food and Drug Administration approved ...
Deaths from COVID-19 have slowed significantly but continue adding to a tally of more than 7 million deaths from the virus in the nearly five years since the World Health Organization (WHO) declared a ...
TORONTO, March 20, 2023 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results